Envelope
For further information, please contact us on 01249 466 966, Monday to Friday 9am-5.30pm, or email us

What is oral mucositis?
Painful oral lesions come in a variety of forms, from multiple small ulcers to more severe conditions such as oral mucositis. Oral mucositis is characterised by unpleasant, painful ulcers and inflammation in the mouth.

In some cases oral mucositis can cause severe discomfort or pain and may even prevent swallowing of food and fluids.
Who is affected by oral mucositis? Show/Hide

Oral mucositis affects people who are receiving radiotherapy and/or chemotherapy for a wide variety of reasons:
  • 85−100% of patients receiving radiotherapy for head and neck cancer1
    • 25−45% had severe oral mucositis
  • 75−100% of patients receiving stem-cell transplantation (chemotherapy is used to prepare the patient's system beforehand)1
    • 25−60% had severe oral mucositis
  • 5−40% of patients receiving treatment for solid tumours with myelosuppressive chemotherapy1
However, the true incidence of oral mucositis may be even higher as oral mucositis that is not classed as 'severe', but which may have an impact on patients' comfort, is not consistently reported.2

Hide
What problems can oral mucositis cause? Show/Hide

Oral mucositis doesn't just cause pain; it can also affect disease management and treatment outcomes. Oral mucositis can lead to:
  • Increased risk of infection and fever3
  • Prolonged hospitalisation3
  • Adjustment of anti-cancer therapy2,3
  • Need for artificial nutrition (i.e. a feeding tube)2,3
  • Need for strong painkillers (e.g. opioids)3
  • Increased weight loss3
  • Restricted mouth care4
  • Impaired speech4
Oral mucositis can also have a significant impact on healthcare resources. American studies have estimated extra costs associated with oral mucositis to be in the region of £920 to £3750 per patient,* depending on severity.3,5

*Based on the results of two US studies.3,5 Figures are converted from US$ using average exchange rates for the period of study data collection.

Hide
What causes oral mucositis? Show/Hide

Oral mucositis is caused by a breakdown of the oral mucosa usually related to chemotherapy or radiotherapy. The diagram below shows how this happens. What causes oral mucositis

Hide
When do symptoms develop? Show/Hide

Chemotherapy: symptoms usually develop between days four and five, peaking after seven to ten days.6

Radiotherapy to the head and neck: symptoms will usually start one to two weeks after first dose of radiotherapy and usually continue for one to three weeks after therapy is completed.6



Hide
How is oral mucositis managed? Show/Hide

Encouraging meticulous oral hygiene is important in preventing and managing oral mucositis. The joint Multinational Association of Supportive Care In Cancer (MASCC) and International Society of Oral Oncology (ISOO) guidelines (2007) for oral mucositis recommend:7
  • Initial and ongoing assessment of the oral cavity using validated instruments that include both patient self-report and professional examination
  • Regular, systematic, oral care hygiene with brushing, flossing, bland rinses and moisturisers using a standardised oral care protocol should be implemented for all patients
  • Use of a soft toothbrush, replaced on a regular basis
  • Dental examinations and treatment prior to the start of cancer therapy for all patients, especially those with head and neck cancer, which should continue throughout active treatment and follow-up.
Management strategies for oral mucositis include:
  • Bland rinses8
  • Topical anaesthetics8
  • Analgesics8
  • Keratinocyte growth factor-18
  • Low level laser treatment7
  • Mucosal coating agents, such as Gelclair®8
Gelclair® is an oral gel that helps to relieve the pain associated with oral mucositis and other treatment-related oral lesions.9-11 Gelclair® does this by forming a bioprotective coating inside the mouth, offering rapid and effective pain management.9-11

To find out more about how Gelclair® works and the clinical evidence
supporting it, click here or click on the "About Gelclair®" tab at the top of the page.

Hide
Reporting of side effects

Medical device adverse incidents should be reported to the MHRA. Reporting information can be found at www.mhra.gov.uk. Any adverse event should also be reported to Pharmacovigilance at Alliance Pharmaceuticals Limited (tel: 01249 466 966, email:pharmacovigilance@alliancepharma.co.uk).
Find out more about the effects of oral mucositis on patients' lives
Watch and read the stories of oral mucositis patients' experiences of using Gelclair during their treatment for cancer.
To watch videos of other people's experiences with oral mucositis, click here
This animation shows how Gelclair can help to relieve the pain of oral lesions and ulcers caused by oral mucositis.
Tell friends about Gelclair which helps to relieve the pain of oral lesions and ulcers from oral mucositis.
For further information, please contact us on 01249 466 966, Monday to Friday 9am-5.30pm, or email us

You are now leaving the UK healthcare professionals section of the website.

You will be returned to the public section of the website.

OK